齊翔騰達(002408.SZ):與藍帆醫療簽署戰略合作框架協議
格隆匯 11 月 30日丨齊翔騰達(002408.SZ)公佈,公司於2020年11月30日與藍帆醫療股份有限公司(“藍帆醫療”)簽署《戰略合作框架協議》。
訂購產品數量及價格:(1)自2020年12月1日至2021年12月31日,公司作為乙方銷售給甲方藍帆醫療羧基丁腈膠乳不低於30000噸;(2)此後每年度羧基丁腈膠乳合作數量由雙方於前一年度的12月份前確認;(3)如雙方需變更購銷數量,應提前告知對方,雙方平衡計劃後協商確定;(4)銷售價格按照雙方銷售時訂單協商價格為準。
公司與藍帆醫療簽訂《戰略合作框架協議》,能夠緩解公司丁腈膠乳產能釋放對於市場的衝擊,同時對公司在合同執行年度內的經營業績將產生積極影響,有利於提升公司的持續盈利能力,有利於公司長遠發展。
此次簽訂的《戰略合作框架協議》為公司現有產品領域的銷售類合同,公司在資金、人員、技術及產能方面均具備履行上述協議的能力;公司與交易對方不存在任何關聯關係,《戰略合作框架協議》的履行對公司業務的獨立性無影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.